| 0 |
PARANEOPLASTIC RASH |
8 |
0.2857 |
| 1 |
ANTI A ANTIBODY |
1 |
0.1250 |
| 2 |
NON-SMALL CELL LUNG CANCER STAGE II |
1 |
0.0526 |
| 3 |
BLOOD ELECTROLYTES INCREASED |
5 |
0.0427 |
| 4 |
ANTIDIURETIC HORMONE ABNORMALITY |
2 |
0.0238 |
| 5 |
BROWN-SEQUARD SYNDROME |
1 |
0.0147 |
| 6 |
RAPID CORRECTION OF HYPONATRAEMIA |
3 |
0.0120 |
| 7 |
MENTAL STATUS CHANGES POSTOPERATIVE |
1 |
0.0094 |
| 8 |
NON-CARDIOGENIC PULMONARY OEDEMA |
6 |
0.0057 |
| 9 |
THYROID PAIN |
1 |
0.0056 |
| 10 |
RENAL TUBULAR DYSFUNCTION |
3 |
0.0053 |
| 11 |
RETICULOCYTOSIS |
1 |
0.0047 |
| 12 |
MUSCLE OEDEMA |
1 |
0.0046 |
| 13 |
DIABETES INSIPIDUS |
11 |
0.0046 |
| 14 |
AUTOIMMUNE NEPHRITIS |
1 |
0.0045 |
| 15 |
NEPHROGENIC DIABETES INSIPIDUS |
5 |
0.0043 |
| 16 |
LUNG ADENOCARCINOMA METASTATIC |
1 |
0.0043 |
| 17 |
ILIAC ARTERY OCCLUSION |
1 |
0.0036 |
| 18 |
FEMORAL ARTERY OCCLUSION |
1 |
0.0032 |
| 19 |
TUMOUR MARKER ABNORMAL |
1 |
0.0030 |
| 20 |
SOFT TISSUE INFLAMMATION |
1 |
0.0030 |
| 21 |
OSMOTIC DEMYELINATION SYNDROME |
2 |
0.0027 |
| 22 |
QRS AXIS ABNORMAL |
2 |
0.0026 |
| 23 |
METASTASES TO STOMACH |
1 |
0.0026 |
| 24 |
BIOPSY BONE MARROW |
1 |
0.0021 |
| 25 |
PERIPHERAL ARTERY STENOSIS |
1 |
0.0021 |
| 26 |
PULMONARY VALVE INCOMPETENCE |
3 |
0.0021 |
| 27 |
METASTASES TO ABDOMINAL CAVITY |
1 |
0.0020 |
| 28 |
BLADDER MASS |
1 |
0.0020 |
| 29 |
RETROPERITONEAL LYMPHADENOPATHY |
1 |
0.0019 |
| 30 |
COATING IN MOUTH |
1 |
0.0019 |
| 31 |
BLOOD SODIUM INCREASED |
5 |
0.0019 |
| 32 |
METASTASES TO KIDNEY |
1 |
0.0018 |
| 33 |
DILATATION ATRIAL |
2 |
0.0017 |
| 34 |
STRIDOR |
5 |
0.0017 |
| 35 |
LUNG ADENOCARCINOMA |
5 |
0.0017 |
| 36 |
MITRAL VALVE CALCIFICATION |
1 |
0.0016 |
| 37 |
CARDIAC VENTRICULAR THROMBOSIS |
2 |
0.0015 |
| 38 |
ILEAL PERFORATION |
1 |
0.0015 |
| 39 |
ORAL MUCOSAL DISCOLOURATION |
1 |
0.0015 |
| 40 |
MUCOSAL DRYNESS |
3 |
0.0015 |
| 41 |
ELECTROCARDIOGRAM ST-T CHANGE |
1 |
0.0014 |
| 42 |
HYPERNATRAEMIA |
7 |
0.0014 |
| 43 |
NEUTROPENIC SEPSIS |
10 |
0.0014 |
| 44 |
AORTIC VALVE SCLEROSIS |
1 |
0.0014 |
| 45 |
CAUDA EQUINA SYNDROME |
1 |
0.0013 |
| 46 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 47 |
INTERVERTEBRAL DISC SPACE NARROWING |
1 |
0.0012 |
| 48 |
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL |
1 |
0.0012 |
| 49 |
HYPERAMMONAEMIA |
6 |
0.0012 |
| 50 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 51 |
LUNG HYPERINFLATION |
1 |
0.0012 |
| 52 |
NON-SMALL CELL LUNG CANCER METASTATIC |
1 |
0.0011 |
| 53 |
BLOOD CREATINE INCREASED |
5 |
0.0011 |
| 54 |
METASTASES TO ADRENALS |
1 |
0.0011 |
| 55 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 56 |
NON-SMALL CELL LUNG CANCER |
5 |
0.0010 |
| 57 |
SKIN OEDEMA |
1 |
0.0010 |
| 58 |
DECUBITUS ULCER |
8 |
0.0010 |
| 59 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
10 |
0.0010 |
| 60 |
BONE MARROW OEDEMA |
1 |
0.0010 |
| 61 |
BONE NEOPLASM |
1 |
0.0009 |
| 62 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 63 |
METASTASES TO MENINGES |
2 |
0.0009 |
| 64 |
GASTROINTESTINAL BACTERIAL INFECTION |
1 |
0.0009 |
| 65 |
TOXIC ENCEPHALOPATHY |
4 |
0.0008 |
| 66 |
TRANSITIONAL CELL CARCINOMA |
1 |
0.0008 |
| 67 |
TUMOUR PAIN |
1 |
0.0008 |
| 68 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
1 |
0.0008 |
| 69 |
HYPONATRAEMIA |
41 |
0.0007 |
| 70 |
ALVEOLITIS |
1 |
0.0007 |
| 71 |
AORTIC VALVE INCOMPETENCE |
3 |
0.0007 |
| 72 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 73 |
OSTEOSCLEROSIS |
1 |
0.0006 |
| 74 |
INTERMITTENT CLAUDICATION |
1 |
0.0006 |
| 75 |
HISTOPLASMOSIS DISSEMINATED |
1 |
0.0006 |
| 76 |
LYMPHOCYTE COUNT DECREASED |
11 |
0.0006 |
| 77 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 78 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 79 |
HYPOMAGNESAEMIA |
8 |
0.0006 |
| 80 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 81 |
SCLERODERMA |
2 |
0.0005 |
| 82 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 83 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 84 |
ADRENAL DISORDER |
1 |
0.0005 |
| 85 |
ATROPHY |
1 |
0.0005 |
| 86 |
EARLY SATIETY |
1 |
0.0005 |
| 87 |
PURULENCE |
1 |
0.0005 |
| 88 |
CONCOMITANT DISEASE PROGRESSION |
1 |
0.0005 |
| 89 |
HYPOPHYSITIS |
1 |
0.0005 |
| 90 |
OSTEOLYSIS |
1 |
0.0005 |
| 91 |
CONGESTIVE CARDIOMYOPATHY |
2 |
0.0005 |
| 92 |
JAW FRACTURE |
1 |
0.0005 |
| 93 |
EXPOSED BONE IN JAW |
1 |
0.0005 |
| 94 |
AGRANULOCYTOSIS |
8 |
0.0004 |
| 95 |
GASTRITIS EROSIVE |
2 |
0.0004 |
| 96 |
PERFORMANCE STATUS DECREASED |
2 |
0.0004 |
| 97 |
BLOOD SODIUM DECREASED |
8 |
0.0004 |
| 98 |
RADIUS FRACTURE |
1 |
0.0004 |
| 99 |
HUMERUS FRACTURE |
2 |
0.0004 |
| 100 |
GLOMERULAR FILTRATION RATE DECREASED |
5 |
0.0004 |
| 101 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 102 |
ILEOSTOMY |
1 |
0.0004 |
| 103 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 104 |
TRICUSPID VALVE INCOMPETENCE |
3 |
0.0004 |
| 105 |
GASTROINTESTINAL STROMAL TUMOUR |
1 |
0.0004 |
| 106 |
ABDOMINAL MASS |
1 |
0.0004 |
| 107 |
DIABETIC COMA |
1 |
0.0004 |
| 108 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 109 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 110 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 111 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 112 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 113 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 114 |
PEPTIC ULCER |
1 |
0.0003 |
| 115 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 116 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 117 |
WHITE BLOOD CELL COUNT INCREASED |
11 |
0.0003 |
| 118 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 119 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 120 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 121 |
THYROID MASS |
1 |
0.0003 |
| 122 |
PROSTATOMEGALY |
1 |
0.0003 |
| 123 |
POLYDIPSIA |
1 |
0.0003 |
| 124 |
HAEMATOCRIT DECREASED |
5 |
0.0003 |
| 125 |
MENTAL STATUS CHANGES |
7 |
0.0003 |
| 126 |
AZOTAEMIA |
1 |
0.0003 |
| 127 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 128 |
NEUTROPHIL COUNT DECREASED |
10 |
0.0002 |
| 129 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 130 |
DYSURIA |
9 |
0.0002 |
| 131 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 132 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 133 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 134 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 135 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 136 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 137 |
CONTRAINDICATED PRODUCT ADMINISTERED |
7 |
0.0002 |
| 138 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 139 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 140 |
INTENTIONAL DEVICE MISUSE |
1 |
0.0002 |
| 141 |
LUNG INFILTRATION |
2 |
0.0002 |
| 142 |
THIRST |
4 |
0.0002 |
| 143 |
BLOOD BILIRUBIN INCREASED |
6 |
0.0002 |
| 144 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 145 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 146 |
SYNOVIAL CYST |
1 |
0.0002 |
| 147 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 148 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 149 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0002 |
| 150 |
DRUG PRESCRIBING ERROR |
4 |
0.0002 |
| 151 |
FAECAL INCONTINENCE |
1 |
0.0002 |
| 152 |
APHAGIA |
1 |
0.0002 |
| 153 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 154 |
ENCEPHALOPATHY |
5 |
0.0002 |
| 155 |
HOSPICE CARE |
2 |
0.0002 |
| 156 |
LEUKOPENIA |
10 |
0.0002 |
| 157 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 158 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 159 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 160 |
NYSTAGMUS |
1 |
0.0002 |
| 161 |
STRESS FRACTURE |
1 |
0.0002 |
| 162 |
METASTASES TO BONE |
3 |
0.0002 |
| 163 |
FAECALOMA |
1 |
0.0002 |
| 164 |
BLOOD GLUCOSE FLUCTUATION |
2 |
0.0002 |
| 165 |
STEVENS-JOHNSON SYNDROME |
4 |
0.0002 |
| 166 |
NECROSIS |
1 |
0.0002 |
| 167 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 168 |
SKIN TOXICITY |
1 |
0.0002 |
| 169 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 170 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 171 |
ENERGY INCREASED |
1 |
0.0002 |
| 172 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 173 |
INGUINAL HERNIA |
1 |
0.0002 |
| 174 |
SPINAL OPERATION |
2 |
0.0002 |
| 175 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 176 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 177 |
SCOLIOSIS |
1 |
0.0002 |
| 178 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 179 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 180 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 181 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 182 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 183 |
OEDEMA PERIPHERAL |
18 |
0.0001 |
| 184 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 185 |
JOINT EFFUSION |
1 |
0.0001 |
| 186 |
PAIN IN JAW |
4 |
0.0001 |
| 187 |
HAND FRACTURE |
1 |
0.0001 |
| 188 |
EATING DISORDER |
3 |
0.0001 |
| 189 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 190 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 191 |
BLOOD CREATININE INCREASED |
9 |
0.0001 |
| 192 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 193 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 194 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 195 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 196 |
STOMATITIS |
8 |
0.0001 |
| 197 |
ACIDOSIS |
1 |
0.0001 |
| 198 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 199 |
BLOOD DISORDER |
1 |
0.0001 |
| 200 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 201 |
MUSCLE DISORDER |
1 |
0.0001 |
| 202 |
BACK DISORDER |
2 |
0.0001 |
| 203 |
DYSPHONIA |
7 |
0.0001 |
| 204 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 205 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 206 |
ATRIAL FIBRILLATION |
11 |
0.0001 |
| 207 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 208 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 209 |
HAEMARTHROSIS |
1 |
0.0001 |
| 210 |
MYOSITIS |
1 |
0.0001 |
| 211 |
EXOSTOSIS |
1 |
0.0001 |
| 212 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 213 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 214 |
APPENDICITIS |
1 |
0.0001 |
| 215 |
DEFORMITY |
1 |
0.0001 |
| 216 |
EPISTAXIS |
8 |
0.0001 |
| 217 |
PHOTOPHOBIA |
2 |
0.0001 |
| 218 |
LACERATION |
1 |
0.0001 |
| 219 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 220 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 221 |
DEHYDRATION |
14 |
0.0001 |
| 222 |
INCREASED APPETITE |
2 |
0.0001 |
| 223 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 224 |
THERAPY CHANGE |
1 |
0.0001 |
| 225 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 226 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 227 |
SPINAL FRACTURE |
2 |
0.0001 |
| 228 |
CARDIAC FAILURE |
8 |
0.0001 |
| 229 |
EMPHYSEMA |
1 |
0.0001 |
| 230 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 231 |
EUPHORIC MOOD |
1 |
0.0001 |
| 232 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 233 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 234 |
TRANSFUSION |
1 |
0.0001 |
| 235 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 236 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 237 |
SYNCOPE |
9 |
0.0001 |
| 238 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 239 |
MALNUTRITION |
1 |
0.0001 |
| 240 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 241 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 242 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 243 |
CONVULSION |
5 |
0.0001 |
| 244 |
MYOCARDITIS |
1 |
0.0001 |
| 245 |
NEOPLASM |
1 |
0.0001 |
| 246 |
HYPERKALAEMIA |
3 |
0.0001 |
| 247 |
ACUTE KIDNEY INJURY |
13 |
0.0001 |
| 248 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 249 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 250 |
ATAXIA |
1 |
0.0001 |
| 251 |
NEUROPATHY PERIPHERAL |
8 |
0.0001 |
| 252 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 253 |
BURSITIS |
1 |
0.0001 |
| 254 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 255 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 256 |
CARDIOMEGALY |
1 |
0.0001 |
| 257 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 258 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 259 |
ILEUS |
1 |
0.0001 |
| 260 |
COLITIS |
3 |
0.0001 |
| 261 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 262 |
HYPOPHAGIA |
2 |
0.0001 |
| 263 |
ANOREXIA |
1 |
0.0001 |
| 264 |
HIATUS HERNIA |
1 |
0.0001 |
| 265 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 266 |
ANHEDONIA |
2 |
0.0001 |
| 267 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 268 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 269 |
JAUNDICE |
2 |
0.0001 |
| 270 |
SINUS CONGESTION |
1 |
0.0001 |
| 271 |
SKIN LESION |
2 |
0.0001 |
| 272 |
HUNGER |
1 |
0.0001 |
| 273 |
PANCYTOPENIA |
4 |
0.0001 |
| 274 |
MASS |
1 |
0.0001 |
| 275 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 276 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 277 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 278 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 279 |
PARALYSIS |
1 |
0.0001 |
| 280 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 281 |
BONE PAIN |
4 |
0.0001 |
| 282 |
RENAL INJURY |
2 |
0.0001 |
| 283 |
PULMONARY MASS |
1 |
0.0001 |
| 284 |
NEUTROPENIA |
9 |
0.0001 |
| 285 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 286 |
OSTEOPENIA |
1 |
0.0001 |
| 287 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 288 |
INSURANCE ISSUE |
1 |
0.0001 |
| 289 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 290 |
HYPOKALAEMIA |
3 |
0.0001 |
| 291 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 292 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 293 |
MENINGIOMA |
1 |
0.0001 |
| 294 |
CYANOSIS |
1 |
0.0001 |
| 295 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 296 |
CYSTITIS |
2 |
0.0001 |
| 297 |
SCIATICA |
1 |
0.0001 |
| 298 |
CONFUSIONAL STATE |
10 |
0.0001 |
| 299 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 300 |
CONSTIPATION |
13 |
0.0001 |
| 301 |
FLUID RETENTION |
3 |
0.0001 |
| 302 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 303 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 304 |
MALIGNANT NEOPLASM PROGRESSION |
6 |
0.0001 |
| 305 |
ASTHENIA |
22 |
0.0001 |
| 306 |
HAEMOGLOBIN DECREASED |
6 |
0.0001 |
| 307 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 308 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 309 |
METASTASES TO LIVER |
1 |
0.0001 |
| 310 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 311 |
OSTEOMYELITIS |
1 |
0.0001 |
| 312 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 313 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 314 |
CHEST PAIN |
10 |
0.0001 |
| 315 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 316 |
FEELING JITTERY |
1 |
0.0001 |
| 317 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 318 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 319 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 320 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 321 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 322 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 323 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 324 |
ABDOMINAL PAIN |
11 |
0.0000 |
| 325 |
PNEUMONIA |
15 |
0.0000 |
| 326 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 327 |
TOOTH DISORDER |
1 |
0.0000 |
| 328 |
GLOSSODYNIA |
1 |
0.0000 |
| 329 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 330 |
ORAL PAIN |
1 |
0.0000 |
| 331 |
SNEEZING |
1 |
0.0000 |
| 332 |
ABDOMINAL PAIN UPPER |
9 |
0.0000 |
| 333 |
SEIZURE |
5 |
0.0000 |
| 334 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 335 |
ANAEMIA |
8 |
0.0000 |
| 336 |
DIARRHOEA |
27 |
0.0000 |
| 337 |
PRESYNCOPE |
1 |
0.0000 |
| 338 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 339 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 340 |
AGEUSIA |
1 |
0.0000 |
| 341 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 342 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 343 |
HEPATITIS |
1 |
0.0000 |
| 344 |
DECREASED APPETITE |
9 |
0.0000 |
| 345 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 346 |
SPEECH DISORDER |
2 |
0.0000 |
| 347 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 348 |
PANCREATITIS |
2 |
0.0000 |
| 349 |
RENAL FAILURE |
5 |
0.0000 |
| 350 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 351 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 352 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 353 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 354 |
FEELING COLD |
1 |
0.0000 |
| 355 |
WOUND |
1 |
0.0000 |
| 356 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 357 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 358 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 359 |
ANGINA PECTORIS |
1 |
0.0000 |
| 360 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 361 |
BACK PAIN |
8 |
0.0000 |
| 362 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 363 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 364 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 365 |
FEMUR FRACTURE |
1 |
0.0000 |
| 366 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 367 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 368 |
HEAD INJURY |
1 |
0.0000 |
| 369 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 370 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 371 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 372 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 373 |
DIZZINESS |
15 |
0.0000 |
| 374 |
FUNGAL INFECTION |
1 |
0.0000 |
| 375 |
URINARY RETENTION |
1 |
0.0000 |
| 376 |
HYPOTENSION |
6 |
0.0000 |
| 377 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 378 |
HEART RATE DECREASED |
1 |
0.0000 |
| 379 |
HYPERTENSION |
6 |
0.0000 |
| 380 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 381 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 382 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 383 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 384 |
MOBILITY DECREASED |
2 |
0.0000 |
| 385 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 386 |
MALAISE |
12 |
0.0000 |
| 387 |
DYSGEUSIA |
2 |
0.0000 |
| 388 |
SEPSIS |
3 |
0.0000 |
| 389 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 390 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 391 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 392 |
PYREXIA |
9 |
0.0000 |
| 393 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 394 |
DRUG INTERACTION |
4 |
0.0000 |
| 395 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 396 |
ANXIETY |
7 |
0.0000 |
| 397 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 398 |
OSTEOPOROSIS |
1 |
0.0000 |
| 399 |
TREATMENT FAILURE |
2 |
0.0000 |
| 400 |
TREMOR |
4 |
0.0000 |
| 401 |
FALL |
8 |
0.0000 |
| 402 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 403 |
POLLAKIURIA |
1 |
0.0000 |
| 404 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 405 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 406 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 407 |
SEPTIC SHOCK |
1 |
0.0000 |
| 408 |
MENTAL DISORDER |
1 |
0.0000 |
| 409 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 410 |
THROAT IRRITATION |
1 |
0.0000 |
| 411 |
FATIGUE |
17 |
0.0000 |
| 412 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 413 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 414 |
CARDIAC DISORDER |
2 |
0.0000 |
| 415 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 416 |
ARRHYTHMIA |
1 |
0.0000 |
| 417 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 418 |
MIGRAINE |
2 |
0.0000 |
| 419 |
INFECTION |
3 |
0.0000 |
| 420 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 421 |
HYPOAESTHESIA |
3 |
0.0000 |
| 422 |
CELLULITIS |
1 |
0.0000 |
| 423 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 424 |
ILLNESS |
2 |
0.0000 |
| 425 |
ECZEMA |
1 |
0.0000 |
| 426 |
NAUSEA |
15 |
0.0000 |
| 427 |
BRADYCARDIA |
1 |
0.0000 |
| 428 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 429 |
RASH PRURITIC |
1 |
0.0000 |
| 430 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 431 |
MEDICATION ERROR |
1 |
0.0000 |
| 432 |
WEIGHT DECREASED |
5 |
0.0000 |
| 433 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 434 |
MYALGIA |
3 |
0.0000 |
| 435 |
HERPES ZOSTER |
1 |
0.0000 |
| 436 |
EYE IRRITATION |
1 |
0.0000 |
| 437 |
CHILLS |
2 |
0.0000 |
| 438 |
SURGERY |
1 |
0.0000 |
| 439 |
NASAL CONGESTION |
1 |
0.0000 |
| 440 |
JOINT SWELLING |
2 |
0.0000 |
| 441 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 442 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 443 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 444 |
VERTIGO |
1 |
0.0000 |
| 445 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 446 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 447 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 448 |
PRURITUS |
6 |
0.0000 |
| 449 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 450 |
INSOMNIA |
4 |
0.0000 |
| 451 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 452 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 453 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 454 |
BURNING SENSATION |
1 |
0.0000 |
| 455 |
INJURY |
1 |
0.0000 |
| 456 |
DEATH |
12 |
0.0000 |
| 457 |
UNDERDOSE |
1 |
0.0000 |
| 458 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 459 |
BRONCHITIS |
1 |
0.0000 |
| 460 |
WEIGHT INCREASED |
3 |
0.0000 |
| 461 |
HOT FLUSH |
1 |
0.0000 |
| 462 |
CARDIAC ARREST |
1 |
0.0000 |
| 463 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 464 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 465 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 466 |
BALANCE DISORDER |
1 |
0.0000 |
| 467 |
RASH |
5 |
0.0000 |
| 468 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 469 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 470 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 471 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 472 |
PAIN |
7 |
0.0000 |
| 473 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 474 |
DEVICE ISSUE |
1 |
0.0000 |
| 475 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 476 |
MUSCLE SPASMS |
2 |
0.0000 |
| 477 |
ADVERSE EVENT |
1 |
0.0000 |
| 478 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 479 |
COUGH |
3 |
0.0000 |
| 480 |
SWELLING |
1 |
0.0000 |
| 481 |
DYSPHAGIA |
1 |
0.0000 |
| 482 |
SOMNOLENCE |
2 |
0.0000 |
| 483 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 484 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 485 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 486 |
INFLUENZA |
1 |
0.0000 |
| 487 |
ASTHMA |
1 |
0.0000 |
| 488 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 489 |
DEPRESSION |
2 |
0.0000 |
| 490 |
OFF LABEL USE |
7 |
0.0000 |
| 491 |
HYPERHIDROSIS |
1 |
0.0000 |
| 492 |
DRY SKIN |
1 |
0.0000 |
| 493 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 494 |
ARTHRALGIA |
3 |
0.0000 |
| 495 |
VOMITING |
3 |
0.0000 |
| 496 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 497 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 498 |
COVID-19 |
1 |
0.0000 |
| 499 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 500 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 501 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 502 |
DYSPNOEA |
3 |
0.0000 |
| 503 |
ALOPECIA |
1 |
0.0000 |
| 504 |
HEADACHE |
3 |
0.0000 |
| 505 |
OVERDOSE |
1 |
0.0000 |
| 506 |
FEELING ABNORMAL |
1 |
0.0000 |
| 507 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 508 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 509 |
DRUG INEFFECTIVE |
4 |
0.0000 |